Dr. Zhengming Su is a dedicated clinician, researcher, and educator specializing in urology. Born in September 1988 in Zhanjiang, Guangdong, China, Dr. Su has established himself as a skilled attending physician at the Fifth Affiliated Hospital of Guangzhou Medical University. He possesses extensive experience in the diagnosis and treatment of urinary calculi, urinary tumors, and male reproductive system diseases. Over the years, Dr. Su has performed approximately 2000 surgical procedures, including advanced minimally invasive and robotic-assisted surgeries. His commitment to medical education is evident through his role as a teaching secretary, where he has significantly contributed to clinical training programs. Additionally, he has actively pursued scientific research, securing multiple research projects at provincial and university levels, and has published extensively in peer-reviewed journals. Dr. Su’s research focuses on molecular mechanisms underlying urological cancers, with particular attention to microRNAs and their regulatory pathways. His clinical and research work is complemented by his dedication to continuous learning, as he further hones his expertise through specialized training in robotic surgery. Dr. Su’s professional journey reflects a balance between patient care, academic contribution, and innovative research, making him a valuable asset to the medical community and a promising candidate for recognition in his field.
Professional Profile
Education
Dr. Zhengming Su has pursued a comprehensive medical education, starting with his Bachelor of Clinical Medicine from Shantou University School of Medicine, completed between 2007 and 2012. During his undergraduate studies, he developed a solid foundation in medical science and clinical practice, which laid the groundwork for his surgical career. Building on this, he completed his postgraduate degree at Shantou University School of Medicine from 2012 to 2015, earning a Master’s degree in Surgery under the supervision of Professor Ye Jiongxian at Shenzhen Hospital, Peking University. His postgraduate work allowed him to specialize in urological surgery, deepening his clinical skills and research capabilities. Demonstrating a commitment to lifelong learning and scientific advancement, Dr. Su is currently a PhD candidate at Guangzhou Medical University, starting in September 2024. His academic trajectory reflects a consistent effort to advance his knowledge in clinical medicine and medical research. Throughout his educational journey, Dr. Su has focused on urology and oncology, positioning himself at the intersection of clinical excellence and scientific discovery. His formal training has been complemented by specialized studies in robotic-assisted surgery, solidifying his expertise in complex surgical techniques. Dr. Su’s education has prepared him to contribute meaningfully to both clinical care and academic research.
Professional Experience
Dr. Zhengming Su’s professional career is rooted in the Department of Urology at the Fifth Affiliated Hospital of Guangzhou Medical University, where he has served since July 2015. Starting as a resident physician and later promoted to attending physician, he has gained hands-on experience managing a wide range of urological conditions. Dr. Su’s clinical practice includes approximately 2000 surgeries, covering advanced techniques such as transurethral procedures, percutaneous nephrolithotomy, laparoscopic surgeries, and robot-assisted laparoscopic operations. From October 2021 to April 2022, he underwent specialized training at the First Affiliated Hospital of Naval Medical University (Changhai Hospital) in Shanghai, focusing on complex urinary stone surgeries and robotic-assisted treatments for urinary tumors. His expertise extends beyond the operating room; between 2016 and 2021, he served as the teaching secretary and secretary of the resident training base at his institution, actively contributing to the education of medical students and residents. Dr. Su has also been involved in curriculum development and clinical skill training. His combined roles in clinical practice, teaching, and research demonstrate his versatility and commitment to holistic medical advancement. His career trajectory underscores his dedication to improving patient care, advancing surgical techniques, and fostering the next generation of medical professionals.
Research Interest
Dr. Zhengming Su’s research interests are deeply rooted in the molecular and clinical aspects of urological diseases, with a strong focus on urinary tract cancers. He has dedicated much of his scientific inquiry to understanding the roles of microRNAs and long non-coding RNAs in the proliferation, invasion, and metastasis of renal cell carcinoma and bladder cancer. Specifically, his studies have examined the regulatory impact of miR-429 on the AKT1 gene, the miR-184/AKT2/mTOR signaling pathway, and the PTEN/AKT signaling cascade in urological malignancies. Dr. Su is also interested in exploring novel surgical techniques and improving clinical outcomes in urology through minimally invasive and robotic-assisted procedures. His involvement in clinical research projects has led to practical applications, such as the use of covered metal stents in the endovascular treatment of ureterovaginal fistula. Additionally, Dr. Su is passionate about enhancing medical education, as evidenced by his research on the effectiveness of the TBL (Team-Based Learning) teaching methodology in urological training. His multidisciplinary research bridges basic science, clinical practice, and educational innovation, contributing to both patient care and medical pedagogy. Dr. Su’s continued exploration of cancer biology and surgical advancements positions him as an emerging leader in translational and clinical urological research.
Research Skills
Dr. Zhengming Su has developed a wide range of research skills that support his clinical and academic endeavors. He is highly proficient in clinical data collection, experimental design, and molecular biology techniques, particularly those related to the study of microRNAs and their influence on cancer pathways. Dr. Su has led multiple research projects that investigated signaling mechanisms involved in renal cell carcinoma and bladder cancer, successfully managing research funding and delivering meaningful scientific outcomes. His ability to apply laboratory findings to clinical challenges demonstrates strong translational research capabilities. Dr. Su is skilled in scientific writing and has a proven track record of publishing articles in reputable international journals, both as a first author and co-author. He also brings valuable experience in the peer-review process, serving as a reviewer for journals such as Oncology Letters and China Tissue Engineering Research. In addition to his laboratory and clinical research proficiency, Dr. Su has demonstrated competency in educational research, focusing on improving teaching methodologies in medical training programs. His ability to integrate clinical practice, research design, and educational strategies highlights his well-rounded research skill set, making him capable of contributing to diverse and impactful scientific initiatives.
Awards and Honors
Throughout his career, Dr. Zhengming Su has received recognition for his contributions to clinical practice, research, and education. Although specific award titles were not detailed in the provided profile, his successful leadership of multiple funded research projects from institutions such as the Guangzhou Medical University and the Guangdong Medical Science and Technology Research Foundation speaks to his professional credibility and the recognition of his scientific work. His selection for advanced training at the First Affiliated Hospital of Naval Medical University, a prestigious institution, reflects both trust in his surgical abilities and acknowledgment of his potential to contribute to the advancement of robotic-assisted urological surgery. Additionally, Dr. Su’s roles as a reviewer for high-impact journals and as a member of the male reproductive medicine branch of the Guangdong Urogenital Association indicate professional respect and acceptance within the broader medical and scientific communities. His active involvement in teaching and curriculum development has also likely earned him recognition within his institution. These professional roles and achievements collectively underscore his status as an emerging leader in urology and academic medicine.
Conclusion
Dr. Zhengming Su exemplifies the qualities of a well-rounded clinician, educator, and researcher. His clinical expertise, particularly in minimally invasive and robot-assisted urological surgeries, is backed by extensive hands-on experience with complex cases. His dedication to improving patient care is matched by his passion for scientific discovery, as reflected in his significant contributions to urological cancer research and his strong publication record in international journals. Additionally, Dr. Su has demonstrated a sustained commitment to medical education, influencing many students and residents through teaching and curriculum development. His research interests, which integrate molecular biology and surgical innovation, are of high relevance to the advancement of modern urology. Dr. Su’s leadership in funded research projects and his active participation in professional organizations further strengthen his profile as a respected medical professional. While international collaborations and publications in higher-impact journals could enhance his academic visibility, his current contributions already position him as a valuable asset to the medical community. Dr. Su is a deserving and competitive candidate for the Best Researcher Award, and his future endeavors are likely to yield continued advancements in both clinical practice and scientific research.
Publications Top Notes
1. Nodularin-R Synergistically Enhances Abiraterone Against Castrate-Resistant Prostate Cancer via PPP1CA Inhibition
-
Authors: Yiqiao Huang, Yi Cen, Hualing Wu, Xianhan Jiang, Anyang Wei, et al.
-
Year: 2024
2. Association of Ulcerative Colitis and Acute Gastroenteritis with Prostate Specific Antigen: Results from National Health and Nutrition Examination Survey (2009 to 2010) and Mendelian Randomization Analyses
-
Authors: Hongxiao Li, Jiefang Zheng, Weimin Dong, Zhengming Su, Xianhan Jiang, et al.
-
Year: 2023
-
Citations: 1
3. The Roles of Long Non-Coding RNAs in Renal Cell Carcinoma (Review)
-
Authors: Zhengming Su, Jian Ao, Fengjin Zhao, Huihua Chen, Chen Gao, et al.
-
Year: Not specified (presumably recent based on context)
-
Citations: 3